• 제목/요약/키워드: nuclear proliferation

검색결과 492건 처리시간 0.04초

핵산합성 억제제인 decitabine과 NF-κB 활성 저해제인 PDTC의 병용 처리에 의한 인체 위암세포사멸 효과 증진 (Increased Apoptotic Efficacy of Decitabine in Combination with an NF-kappaB Inhibitor in Human Gastric Cancer AGS Cells)

  • 최원경;최영현
    • 생명과학회지
    • /
    • 제28권11호
    • /
    • pp.1268-1276
    • /
    • 2018
  • Cytidine analog decitabine (DEC)은 핵산 합성의 억제제로서 골수이형성 증후군 및 급성 골수성 백혈병 치료제로 사용되고 있다. 산화질소 합성에서 번역 단계를 억제하는 것으로 알려진 ammonium pyrrolidine dithiocarbamate (PDTC)는 $NF-{\kappa}B$의 대표적인 억제제이다. 본 연구에서는 인체 위암 AGS 세포를 대상으로 DEC와 PDTC의 병용 처리에 따른 세포증식 억제 기전을 조사하였다. 본 연구의 결과에 따르면 PDTC에 의한 AGS 세포의 증식 억제 효과는 DEC에 의해 농도 의존적으로 유의하게 증가하였으며, 이는 G2/M기의 세포주기 정지 및 apoptosis 유도와 관련이 있었다. PDTC와 DEC의 병용 처리에 의한 세포 사멸의 유도는 DNA 손상 유도와 관련이 있음을 H2AX의 인산화 증가로 확인하였다. 아울러 PDTC와 DEC의 병용 처리는 미토콘드리아 막 전위의 파괴를 유도하고, 세포 내 활성산소종(ROS)의 생성과 Bax의 발현을 향상시키고, Bcl-2 발현을 감소시켰으며 미토콘드리아에서 세포질로의 cytochrome c 유출을 증가시켰다. 또한 PDTC과 DEC의 병용 처리는 외인성 및 내인성 apoptosis 개시 caspase에 해당하는 caspase-8과 caspase-9의 활성뿐만 아니라 caspase-3의 활성화와 PARP 단백질의 분해를 유도하였다. 결론적으로 본 연구의 결과는 PDTC와 DEC의 병용 처리가 DNA 손상을 유발하고, ROS 증가와 연계된 외인성 및 내인성 apoptosis 사멸 경로를 활성화시킴으로써 AGS 세포의 증식을 억제하였음을 의미한다.

Bleomycin Inhibits Proliferation via Schlafen-Mediated Cell Cycle Arrest in Mouse Alveolar Epithelial Cells

  • Jang, Soojin;Ryu, Se Min;Lee, Jooyeon;Lee, Hanbyeol;Hong, Seok-Ho;Ha, Kwon-Soo;Park, Won Sun;Han, Eun-Taek;Yang, Se-Ran
    • Tuberculosis and Respiratory Diseases
    • /
    • 제82권2호
    • /
    • pp.133-142
    • /
    • 2019
  • Background: Idiopathic pulmonary fibrosis involves irreversible alveolar destruction. Although alveolar epithelial type II cells are key functional participants within the lung parenchyma, how epithelial cells are affected upon bleomycin (BLM) exposure remains unknown. In this study, we determined whether BLM could induce cell cycle arrest via regulation of Schlafen (SLFN) family genes, a group of cell cycle regulators known to mediate growth-inhibitory responses and apoptosis in alveolar epithelial type II cells. Methods: Mouse AE II cell line MLE-12 were exposed to $1-10{\mu}g/mL$ BLM and $0.01-100{\mu}M$ baicalein (Bai), a G1/G2 cell cycle inhibitor, for 24 hours. Cell viability and levels of pro-inflammatory cytokines were analyzed by MTT and enzyme-linked immunosorbent assay, respectively. Apoptosis-related gene expression was evaluated by quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR). Cellular morphology was determined after DAPI and Hoechst 33258 staining. To verify cell cycle arrest, propidium iodide (PI) staining was performed for MLE-12 after exposure to BLM. Results: BLM decreased the proliferation of MLE-12 cells. However, it significantly increased expression levels of interleukin 6, tumor necrosis factor ${\alpha}$, and transforming growth factor ${\beta}1$. Based on Hoechst 33258 staining, BLM induced condensation of nuclear and fragmentation. Based on DAPI and PI staining, BLM significantly increased the size of nuclei and induced G2/M phase cell cycle arrest. Results of qRT-PCR analysis revealed that BLM increased mRNA levels of BAX but decreased those of Bcl2. In addition, BLM/Bai increased mRNA levels of p53, p21, SLFN1, 2, 4 of Schlafen family. Conclusion: BLM exposure affects pulmonary epithelial type II cells, resulting in decreased proliferation possibly through apoptotic and cell cycle arrest associated signaling.

APPLICATION OF FUZZY SET THEORY IN SAFEGUARDS

  • Fattah, A.;Nishiwaki, Y.
    • 한국지능시스템학회:학술대회논문집
    • /
    • 한국퍼지및지능시스템학회 1993년도 Fifth International Fuzzy Systems Association World Congress 93
    • /
    • pp.1051-1054
    • /
    • 1993
  • The International Atomic Energy Agency's Statute in Article III.A.5 allows it“to establish and administer safeguards designed to ensure that special fissionable and other materials, services, equipment, facilities and information made available by the Agency or at its request or under its supervision or control are not used in such a way as to further any military purpose; and to apply safeguards, at the request of the parties, to any bilateral or multilateral arrangement, or at the request of a State, to any of that State's activities in the field of atomic energy”. Safeguards are essentially a technical means of verifying the fulfilment of political obligations undertaken by States and given a legal force in international agreements relating to the peaceful uses of nuclear energy. The main political objectives are: to assure the international community that States are complying with their non-proliferation and other peaceful undertakings; and to deter (a) the diversion of afeguarded nuclear materials to the production of nuclear explosives or for military purposes and (b) the misuse of safeguarded facilities with the aim of producing unsafeguarded nuclear material. It is clear that no international safeguards system can physically prevent diversion. The IAEA safeguards system is basically a verification measure designed to provide assurance in those cases in which diversion has not occurred. Verification is accomplished by two basic means: material accountancy and containment and surveillance measures. Nuclear material accountancy is the fundamental IAEA safeguards mechanism, while containment and surveillance serve as important complementary measures. Material accountancy refers to a collection of measurements and other determinations which enable the State and the Agency to maintain a current picture of the location and movement of nuclear material into and out of material balance areas, i. e. areas where all material entering or leaving is measurab e. A containment measure is one that is designed by taking advantage of structural characteristics, such as containers, tanks or pipes, etc. To establish the physical integrity of an area or item by preventing the undetected movement of nuclear material or equipment. Such measures involve the application of tamper-indicating or surveillance devices. Surveillance refers to both human and instrumental observation aimed at indicating the movement of nuclear material. The verification process consists of three over-lapping elements: (a) Provision by the State of information such as - design information describing nuclear installations; - accounting reports listing nuclear material inventories, receipts and shipments; - documents amplifying and clarifying reports, as applicable; - notification of international transfers of nuclear material. (b) Collection by the IAEA of information through inspection activities such as - verification of design information - examination of records and repo ts - measurement of nuclear material - examination of containment and surveillance measures - follow-up activities in case of unusual findings. (c) Evaluation of the information provided by the State and of that collected by inspectors to determine the completeness, accuracy and validity of the information provided by the State and to resolve any anomalies and discrepancies. To design an effective verification system, one must identify possible ways and means by which nuclear material could be diverted from peaceful uses, including means to conceal such diversions. These theoretical ways and means, which have become known as diversion strategies, are used as one of the basic inputs for the development of safeguards procedures, equipment and instrumentation. For analysis of implementation strategy purposes, it is assumed that non-compliance cannot be excluded a priori and that consequently there is a low but non-zero probability that a diversion could be attempted in all safeguards ituations. An important element of diversion strategies is the identification of various possible diversion paths; the amount, type and location of nuclear material involved, the physical route and conversion of the material that may take place, rate of removal and concealment methods, as appropriate. With regard to the physical route and conversion of nuclear material the following main categories may be considered: - unreported removal of nuclear material from an installation or during transit - unreported introduction of nuclear material into an installation - unreported transfer of nuclear material from one material balance area to another - unreported production of nuclear material, e. g. enrichment of uranium or production of plutonium - undeclared uses of the material within the installation. With respect to the amount of nuclear material that might be diverted in a given time (the diversion rate), the continuum between the following two limiting cases is cons dered: - one significant quantity or more in a short time, often known as abrupt diversion; and - one significant quantity or more per year, for example, by accumulation of smaller amounts each time to add up to a significant quantity over a period of one year, often called protracted diversion. Concealment methods may include: - restriction of access of inspectors - falsification of records, reports and other material balance areas - replacement of nuclear material, e. g. use of dummy objects - falsification of measurements or of their evaluation - interference with IAEA installed equipment.As a result of diversion and its concealment or other actions, anomalies will occur. All reasonable diversion routes, scenarios/strategies and concealment methods have to be taken into account in designing safeguards implementation strategies so as to provide sufficient opportunities for the IAEA to observe such anomalies. The safeguards approach for each facility will make a different use of these procedures, equipment and instrumentation according to the various diversion strategies which could be applicable to that facility and according to the detection and inspection goals which are applied. Postulated pathways sets of scenarios comprise those elements of diversion strategies which might be carried out at a facility or across a State's fuel cycle with declared or undeclared activities. All such factors, however, contain a degree of fuzziness that need a human judgment to make the ultimate conclusion that all material is being used for peaceful purposes. Safeguards has been traditionally based on verification of declared material and facilities using material accountancy as a fundamental measure. The strength of material accountancy is based on the fact that it allows to detect any diversion independent of the diversion route taken. Material accountancy detects a diversion after it actually happened and thus is powerless to physically prevent it and can only deter by the risk of early detection any contemplation by State authorities to carry out a diversion. Recently the IAEA has been faced with new challenges. To deal with these, various measures are being reconsidered to strengthen the safeguards system such as enhanced assessment of the completeness of the State's initial declaration of nuclear material and installations under its jurisdiction enhanced monitoring and analysis of open information and analysis of open information that may indicate inconsistencies with the State's safeguards obligations. Precise information vital for such enhanced assessments and analyses is normally not available or, if available, difficult and expensive collection of information would be necessary. Above all, realistic appraisal of truth needs sound human judgment.

  • PDF

흰쥐에서 Iodine-131-Iododeoxyadenosine의 생체분포 및 유방암 영상화에 관한 연구 (Biodistribution and Scintigraphy of Iodine-131-Iododeoxyadenosine in Rats Bearing Breast Cancer)

  • 김선구;김창근;이강모;김혜원;민병철;최시성;이종덕;;;이현철;원종진
    • 대한핵의학회지
    • /
    • 제32권4호
    • /
    • pp.374-381
    • /
    • 1998
  • 목적: 종양을 영상화하기 위해서 I-131-Iododeoxyadenosine (IAD)을 방사합성하여 유방세포가 접종된 쥐를 대상으로 생체분포를 확인하고 신티그라피, 자가방사영상을 시행하여 종양에 잘 섭취되는지를 관찰하였다. 대상 및 방법: Tosyl acetyladenosine을 acetonitrile에 녹인 후 I-131-NaI를 첨가하고 가열하여 IAD를 합성하였다. Female Fisher 344 rat에 유방세포를 피하에 접종하고 3주 후 IAD 0.37 MBq를 주입하고 0.5, 1, 2, 4 및 24시간 후에 각각 3마리씩 희생시켜 주요 장기를 적출하여 %ID/g를 구하였다. 2마리 쥐에 IAD 1.11 MBq를 주입하고 각각 2, 24 시간에 신티그라피를 시행한 후 희생시켜 carboxy-methylcellulose로 블록을 만들어 동결절편기로 $100{\mu}m$ 절편을 얻어 2, 24시간에 각각 자가방사영상을 얻었다. 결과 종양의 섭취(%ID/g)는 주사 후 0.5, 1, 2, 4 및 24시간에 각각 0.74, 0.13, 0.55, 0.38, 0.05이었다. 주사 후 1시간에 종양의 섭취는 심장 (0.34), 간(0.33), 비장(0.47), 신장(0.69), 근육(0.14), 뼈(0.33), 소장(0.51)보다 높았으나, 혈액(1.06), 폐(0.77), 갑상선(177.71)보다는 낮았다. 주사 후 4시간까지 종양의 섭취는 끈 변화가 없었다. 종앙/근육 섭취비는 주사 후 0.5, 1, 2, 4 및 24시간에 각각 4.65, 5.11, 4.91, 4.94 4.10이었고 종양/혈액 섭취비는 주사 후 0.5, 1, 2, 4 및 24시간에 각각 0.68, 0.69, 0.64, 0.67, 0.57로서 섭취비는 시간이 지나도 개선되지는 않았다. 주사 후 2, 24시간에 시행한 신티그라피 및 자가방사영상에서 종양을 잘 관찰 할 수 있었다. 결론: 이 결과는 IAD를 사용하여 종양을 영상화 할 수 있음을 시사하나 종양에의 집적(국소화)을 개선하는 방법이 모색되어야 하겠고 IAD를 이용한 종양영상이 종양세포의 증식을 반영하는지 확인하는 연구가 더 필요할 것으로 사료된다.

  • PDF

Cloning and Functional Characterization of Ptpcd2 as a Novel Cell Cycle Related Protein Tyrosine Phosphatase that Regulates Mitotic Exit

  • Zineldeen, Doaa H.;Wagih, Ayman A.;Nakanishi, Makoto
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권6호
    • /
    • pp.3669-3676
    • /
    • 2013
  • Faithful transmission of genetic information depends on accurate chromosome segregation as cells exit from mitosis, and errors in chromosomal segregation are catastrophic and may lead to aneuploidy which is the hallmark of cancer. In eukaryotes, an elaborate molecular control system ensures proper orchestration of events at mitotic exit. Phosphorylation of specific tyrosyl residues is a major control mechanism for cellular proliferation and the activities of protein tyrosine kinases and phosphatases must be integrated. Although mitotic kinases are well characterized, phosphatases involved in mitosis remain largely elusive. Here we identify a novel variant of mouse protein tyrosine phosphatase containing domain 1 (Ptpcd1), that we named Ptpcd2. Ptpcd1 is a Cdc14 related centrosomal phosphatase. Our newly identified Ptpcd2 shared a significant homology to yeast Cdc14p (34.1%) and other Cdc14 family of phosphatases. By subcellular fractionation Ptpcd2 was found to be enriched in the cytoplasm and nuclear pellets with catalytic phosphatase activity. By means of immunofluorescence, Ptpcd2 was spatiotemporally regulated in a cell cycle dependent manner with cytoplasmic abundance during mitosis, followed by nuclear localization during interphase. Overexpression of Ptpcd2 induced mitotic exit with decreased levels of some mitotic markers. Moreover, Ptpcd2 failed to colocalize with the centrosomal marker ${\gamma}$-tubulin, suggesting it as a non-centrosomal protein. Taken together, Ptpcd2 phosphatase appears a non-centrosomal variant of Ptpcd1 with probable mitotic functions. The identification of this new phosphatase suggests the existence of an interacting phosphatase network that controls mammalian mitosis and provides new drug targets for anticancer modalities.

저농축 우라늄을 사용하는 핵분열 몰리브덴-99 생산에 관련된 방사성 폐기물 연구 (Radioactive Waste Issues Related to Production of Fission-based 99Mo by using Low Enriched Uranium (LEU))

  • 머흐무드 하산;류호진
    • 방사성폐기물학회지
    • /
    • 제13권2호
    • /
    • pp.155-161
    • /
    • 2015
  • 몰리브덴-99의 붕괴에 의해 생산되는 테크네튬-99m 은 방사선 진단에 중요한 역할을 담당하고 있다. 몰리브덴-99 는 주로 우라늄-235의 핵분열에 의해 생산되고 있으며, 이를 위해 고농축 우라늄 표적 또는 저농축 우라늄 표적이 연구로에서 조사된다. 현재는 고농축 우라늄의 사용에 따른 핵확산 문제를 저감하기 위해 저농축 우라늄 표적의 사용이 권장되고 있다. 본 연구는 몰리브덴-99 생산 시설의 계획 단계에서 방사성 폐기물 관리 전략을 정의하기 위하여 저농축 우라늄의 사용이 방사성 폐기물의 흐름에 미치는 영향을 분석하였다. 저농축 우라늄 표적 사용 시 우라늄 함유 폐기물의 부피가 6배 이상 증가하기 때문에 우라늄 고밀도 표적의 사용과 고온 정수압 압축법의 활용이 제안되었다.

방사선조사가 백서 협점막에 미치는 영향에 관한 전자현미경적 연구 (AN ELECTRON MICROSCOPIC STUDY ON THE EFFECTS OF IRRADIATION ON THE BUCCAL MUCOSA OF RAT)

  • 최승규;이상래
    • 치과방사선
    • /
    • 제17권1호
    • /
    • pp.7-20
    • /
    • 1987
  • The author studied the acute reaction of cobalt-60 irradiation to buccal mucosa in rats and difference of the effects of single versus fractionated exposure. 195 Sprague Dowley strain rats, weighing about 120gm, were used in this experiment. 3 rats served as controls and the remaining 192 rats were divided into six groups of 32 rats each. Experimental group Ⅰ, Ⅱ, Ⅲ were received a single dose of 15Gy, 16.5Gy, 18Gy and group Ⅳ, Ⅴ, Ⅵ were received two equal sized fractionated dose of 9Gy, 9.75Gy, 10.5Gy at 4 hour intervals, respectively. The experimental groups were irradiated with cobalt-60 teletherapy unit, Picker model 4M 60 (Field size, 12x5 cm, SSD, 50㎝, Dose rate, 222cGy/min, Depth, 1㎝). The animals were sacrificed at 1, 2, 3, 6, 12 hours, 1, 3, 7 days after irradiation and the changes of the irradiated buccal mucosa were observed by electron and light microscopy. The results were as follows: 1. A single exposure was more damaging than fractionated exposure, and as the radiation dose increased, the changes of cell organelles became faster, but the healing of radiation-induced damage in fractionated exposure was faster than in single exposure. 2. The radiation-induced changes of the basal cells were the most prominent in 18Gy-single exposure group, and the least in 18Gy-fractionated exposure group. 3. Electron-microscopically, there appeared nuclear changes, swelling of mitochondria and rough endoplasmic reticulum, decrease of free ribosome, presence of vesicles, widening of intercellular space, and loss of basal lamina. The early remarkable changes were partly loss of nuclear membrane and swelling of mitochondria. 4. Light-microscopically, derangement and pyknosis of basal cells, hydropic changes of spinous cells, enlargement of granular cells, indistinctness of basement membrane, and proliferation of epithelium were observed.

  • PDF

siRNA Silencing EZH2 Reverses Cisplatin-resistance of Human Non-small Cell Lung and Gastric Cancer Cells

  • Zhou, Wen;Wang, Jian;Man, Wang-Ying;Zhang, Qing-Wei;Xu, Wen-Gui
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권6호
    • /
    • pp.2425-2430
    • /
    • 2015
  • Clinical resistance to chemotherapeutic agents is one of the major hindrances in the treatment of human cancers. EHZ2 is involved in drug resistance and is overexpressed in drug-resistant cancer cell lines. In this study, we investigated the effects of EHZ2 on cisplatin -resistance in A549/DDP and AGS/DDP cells. EHZ2 mRNA and protein were found to be significantly overexpressed in A549/DDP and AGS/DDP cells, compared to parental cells. EHZ2 siRNA successfully silenced EHZ2 mRNA and protein expression. Proliferation was inhibited and drug resistance to cisplatin was improved. Flow cytometry showed that silencing of EHZ2 arrested A549/DDP and AGS/DDP cells in the G0/G1 phase, increasing apoptosis, rh-123 fluorescence intensity and caspase-3/8 activities. Silencing of EHZ2 also significantly reduced the mRNA and protein expression levels of cyclin D1 and MDR1,while up-regulating p15, p21, p27 and miR-218 in A549/DPP cells. Furthermore, silencing of EHZ2 also significantly increased the expression level of tumor suppressor factor miR-218. We also found down-regulating EHZ2 expression increased methylation in A549/DDP and AGS/DDP cells. This study demonstrates that drug resistance can be effectively reversed in human cisplatin-resistant lung and gastric cancer cells through delivery of siRNAs targeting EHZ2.

도깨비부채 잎 추출물의 NF-κB 활성화를 통한 대장암 세포 HCT116에 대한 세포생육 억제활성 (Inhibitory Effect of the Rodgersia podophylla Leave Extracts against Cell Proliferation through Activation of NF-κB in Human Colorectal Cancer Cells)

  • 김정동;정진부
    • 한국자원식물학회지
    • /
    • 제33권5호
    • /
    • pp.460-466
    • /
    • 2020
  • 본 연구 결과들을 바탕으로 도깨비부채 잎(RPL)은 GSK3β활성화를 통해 IκB-α를 인산화시켜 단백질 분해를 유도하고 IκB-α분해로 인해 p65 핵내 전이를 유도하여 NF-κB 신호전달을 활성화시킨다. 이러한 NF-κB 신호전달 활성화를 통해 대장암의 세포생육을 억제하는 것으로 추정된다. 본 결과는 도깨비부채 잎을 소재로 항암을 목적으로 한 천연치료제 및 대체보완소재 개발에 활용할 수 있다고 판단된다. 그러나 도깨비부채 잎의 대장암에 대한 세포생육 억제와 작용기전의 정확한 관련성과 세포생육 억제활성 물질 분석을 위해 추가적인 연구가 필요할 것으로 사료된다.

Aloe vera Inhibits Proliferation of Human Breast and Cervical Cancer Cells and Acts Synergistically with Cisplatin

  • Hussain, Arif;Sharma, Chhavi;Khan, Saniyah;Shah, Kruti;Haque, Shafiul
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권7호
    • /
    • pp.2939-2946
    • /
    • 2015
  • Many of the anti-cancer agents currently used have an origin in natural sources including plants. Aloe vera is one such plant being studied extensively for its diverse health benefits, including cancer prevention. In this study, the cytotoxic potential of Aloe vera crude extract (ACE) alone or in combination with cisplatin in human breast (MCF-7) and cervical (HeLa) cancer cells was studied by cell viability assay, nuclear morphological examination and cell cycle analysis. Effects were correlated with modulation of expression of genes involved in cell cycle regulation, apoptosis and drug metabolism by RT-PCR. Exposure of cells to ACE resulted in considerable loss of cell viability in a dose- and time-dependent fashion, which was found to be mediated by through the apoptotic pathway as evidenced by changes in the nuclear morphology and the distribution of cells in the different phases of the cell cycle. Interestingly, ACE did not have any significant cytotoxicity towards normal cells, thus placing it in the category of safe chemopreventive agent. Further, the effects were correlated with the downregulation of cyclin D1, CYP 1A1, CYP 1A2 and increased expression of bax and p21 in MCF-7 and HeLa cells. In addition, low dose combination of ACE and cisplatin showed a combination index less than 1, indicating synergistic growth inhibition compared to the agents applied individually. In conclusion, these results signify that Aloe vera may be an effective anti-neoplastic agent to inhibit cancer cell growth and increase the therapeutic efficacy of conventional drugs like cispolatin. Thus promoting the development of plant-derived therapeutic agents appears warranted for novel cancer treatment strategies.